Analía Rial Departamento de Desarrollo Biotecnológico Universidad de la República Biography Publications Institution JoVE Articles Analía Rial has not added a biography. If you are Analía Rial and would like to personalize this page please email our Author Liaison for assistance. Publications Ezrin Interagisce Con La Proteina Spike Coronavirus SARS E Trattiene Infezione in Fase Di Iscrizione PloS One. 2012 | Pubmed ID: 23185364 A Single Residue Substitution in the Receptor-binding Domain of H5N1 Hemagglutinin is Critical for Packaging into Pseudotyped Lentiviral Particles PloS One. 2012 | Pubmed ID: 23133587 A Human Coronavirus Responsible for the Common Cold Massively Kills Dendritic Cells but Not Monocytes Journal of Virology. Jul, 2012 | Pubmed ID: 22553325 SARS CoV Subunit Vaccine: Antibody-mediated Neutralisation and Enhancement Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi / Hong Kong Academy of Medicine. Feb, 2012 | Pubmed ID: 22311359 Umani Annexin A6 Interagisce Con Una Proteina M2 Di Virus Influenzale E Modula Negativamente Infezione Journal of Virology. Feb, 2012 | Pubmed ID: 22114333 Classe II ADP-ribosylation Fattori Sono Necessari Per Secrezione Efficiente Del Virus Dengue The Journal of Biological Chemistry. Jan, 2012 | Pubmed ID: 22105072 Anti-severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells Via a PH- and Cysteine Protease-independent FcγR Pathway Journal of Virology. Oct, 2011 | Pubmed ID: 21775467 The SARS Coronavirus E Protein Interacts with PALS1 and Alters Tight Junction Formation and Epithelial Morphogenesis Molecular Biology of the Cell. Nov, 2010 | Pubmed ID: 20861307 Efficient Assembly and Secretion of Recombinant Subviral Particles of the Four Dengue Serotypes Using Native PrM and E Proteins PloS One. 2009 | Pubmed ID: 20016834 Coronin-1A Links Cytoskeleton Dynamics to TCR Alpha Beta-induced Cell Signaling PloS One. 2008 | Pubmed ID: 18941544 The M, E, and N Structural Proteins of the Severe Acute Respiratory Syndrome Coronavirus Are Required for Efficient Assembly, Trafficking, and Release of Virus-like Particles Journal of Virology. Nov, 2008 | Pubmed ID: 18753196 H5-type Influenza Virus Hemagglutinin is Functionally Recognized by the Natural Killer-activating Receptor NKp44 Journal of Virology. Feb, 2008 | Pubmed ID: 18077718 Mutational Spectrum of MYO15A: the Large N-terminal Extension of Myosin XVA is Required for Hearing Human Mutation. Oct, 2007 | Pubmed ID: 17546645 Antibodies Against Trimeric S Glycoprotein Protect Hamsters Against SARS-CoV Challenge Despite Their Capacity to Mediate FcgammaRII-dependent Entry into B Cells in Vitro Vaccine. Jan, 2007 | Pubmed ID: 17049691 The Phenotypic Effect of Hb G-Coushatta [beta22 (B4) Glu-Ala] and Association with IVS.II.1(G-A) in a Turkish Family Genetic Counseling (Geneva, Switzerland). 2005 | Pubmed ID: 16259329 Two Rare Mutations in Turkey: IVS I.130(G-C) and IVS II.848(C-A) Clinical and Laboratory Haematology. Aug, 2005 | Pubmed ID: 16048497 Combination of IVS2.849 A-G WitH IVS1.1 G-A: a Mutation of Beta-globin Gene in a Turkish Beta-thalessemia Major Patient Pediatric Hematology and Oncology. Jun, 2005 | Pubmed ID: 16020116 Differential Maturation and Subcellular Localization of Severe Acute Respiratory Syndrome Coronavirus Surface Proteins S, M and E The Journal of General Virology. May, 2005 | Pubmed ID: 15831954 Molecular Analysis of Beta-thalassemia and Sickle Cell Anemia in Antalya Acta Haematologica. 2004 | Pubmed ID: 15153712 Activation-induced Polarized Recycling Targets T Cell Antigen Receptors to the Immunological Synapse; Involvement of SNARE Complexes Immunity. May, 2004 | Pubmed ID: 15142526 L'immunoterapia sublinguale come alternativa di indurre una protezione contro le infezioni respiratorie acute Natalia Muñoz-Wolf1,2, Analía Rial1, José M. Saavedra1, José A. Chabalgoity1 1Departamento de Desarrollo Biotecnológico, Universidad de la República, 2Present Affiliation: Trinity Biomedical Science Institute, Trinity College Dublin Medicine
L'immunoterapia sublinguale come alternativa di indurre una protezione contro le infezioni respiratorie acute Natalia Muñoz-Wolf1,2, Analía Rial1, José M. Saavedra1, José A. Chabalgoity1 1Departamento de Desarrollo Biotecnológico, Universidad de la República, 2Present Affiliation: Trinity Biomedical Science Institute, Trinity College Dublin Medicine